Pfizer and BioNTech seek authorization of second coronavirus booster shot for people 65 and older
The Washington Post (15 March, 2022) – Pharmaceutical giant Pfizer and its partner, BioNTech, filed Tuesday for emergency authorization of a second booster shot of their coronavirus vaccine for people 65 and older, an effort to bolster waning immunity that occurs several months after the first booster, the companies announced. Pfizer and BioNTech seek […]